Literature DB >> 4380067

Effect of splenectomy on the susceptibility of mice inoculated with Diplococcus pneumoniae.

H R Shinefield, C R Steinberg, D Kaye.   

Abstract

An experimental model is described which demonstrated increased susceptibility of mice to infection with D. pneumoniae following splenectomy. It was necessary to use small numbers of a particular strain of pneumococcus (D. pneumoniae type 6), intravenous infection and a particular strain of mouse (pathogen-free NCS strain). The increase in susceptibility persisted for at least 4 months after splenectomy. With modifications in experimental design such as use of large numbers of organisms, a different strain of pneumococcus, the intraperitoneal route of infection or a different mouse strain no increase or a much less impressive increase in susceptibility was demonstrated. Following intravenous injection of small numbers of D. pneumoniae Type 6 bacteremia tended to persist in all NCS mice. Multiplication of pneumococci subsequently occurred in a higher proportion of mice with splenectomy and at a more rapid rate than in control animals. Mice with splenectomy usually had more D. pneumoniae per ml of blood than per gram of any tissue. This suggested that in these mice multiplication of microorganisms occurs primarily in blood. In control mice higher concentrations of bacteria were present in spleen than in blood, and higher concentrations were found in blood than in other tissues. These results suggested that in normal mice infected intravenously with small numbers of D. pneumoniae Type 6, the spleen protects by removing and killing small but critical numbers of D. pneumoniae which are circulating in the blood. No evidence was found to suggest that the altered susceptibility is mediated by an effect of splenectomy on numbers of circulating leukocytes or on the antibacterial activity of mouse blood.

Entities:  

Mesh:

Year:  1966        PMID: 4380067      PMCID: PMC2138166          DOI: 10.1084/jem.123.5.777

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  8 in total

1.  INFLUENCE OF AUTOIMMUNE HEMOLYTIC ANEMIA ON SUSCEPTIBILITY TO SALMONELLA INFECTION.

Authors:  D KAYE; E W HOOK
Journal:  Proc Soc Exp Biol Med       Date:  1964-10

2.  THE NATURAL HISTORY OF AUTOIMMUNE DISEASE IN NZB MICE. A COMPARISON WITH THE PATTERN OF HUMAN AUTOIMMUNE MANIFESTATIONS.

Authors:  M C HOLMES; F M BURNET
Journal:  Ann Intern Med       Date:  1963-09       Impact factor: 25.391

3.  PNEUMOCOCCAL INFECTIONS IN NORMAL AND SPLENECTOMIZED MONKEYS.

Authors:  S SASLAW; H N CARLISLE
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1964

4.  Influence of splenectomy on resistance to pneumococcal infection in rats.

Authors:  H ROTHBERG; L A CORALLO
Journal:  Proc Soc Exp Biol Med       Date:  1959-02

5.  Relation between splenectomy and subsequent infection. A clinical study.

Authors:  M HORAN; J H COLEBATCH
Journal:  Arch Dis Child       Date:  1962-08       Impact factor: 3.791

6.  Host mechanisms which act to remove bacteria from the blood stream.

Authors:  D E ROGERS
Journal:  Bacteriol Rev       Date:  1960-03

7.  Quantitative study of the granulopectic activity of the reticulo-endothelial system. II. A study of the kinetics of the R. E. S. in relation to the dose of carbon injected; relationship between the weight of the organs and their activity.

Authors:  G BIOZZI; B BENACERRAF; B N HALPERN
Journal:  Br J Exp Pathol       Date:  1953-08

8.  Hazard of severe infections in splenectomized infants and children.

Authors:  C H SMITH; M ERLANDSON; I SCHULMAN; G STERN
Journal:  Am J Med       Date:  1957-03       Impact factor: 4.965

  8 in total
  16 in total

1.  Increased susceptibility of splenectomized mice to infection after exposure to an aerosolized suspension of type III Streptococcus pneumoniae.

Authors:  J A Coil; J D Dickerman; E Boulton
Journal:  Infect Immun       Date:  1978-08       Impact factor: 3.441

2.  Effects of splenectomy on the humoral immune system. A study in neonatally and adult splenectomized mice.

Authors:  J Rozing; N H Brons; R Bennner
Journal:  Immunology       Date:  1978-05       Impact factor: 7.397

3.  Prevention and therapy of bacterial infections for children with asplenia or hyposplenia.

Authors: 
Journal:  Paediatr Child Health       Date:  1999-09       Impact factor: 2.253

4.  The overwhelming postsplenectomy sepsis problem.

Authors:  A S Leonard; G S Giebink; T J Baesl; W Krivit
Journal:  World J Surg       Date:  1980-07       Impact factor: 3.352

5.  The effect of splenectomy on the development of experimental pyelonephritis.

Authors:  M Güngör; O Anğ; D Inanç; I Petorak; H Koyuncuoğlu
Journal:  Experientia       Date:  1981-04-15

6.  Intracellular replication of Streptococcus pneumoniae inside splenic macrophages serves as a reservoir for septicaemia.

Authors:  Giuseppe Ercoli; Vitor E Fernandes; Wen Y Chung; Joseph J Wanford; Sarah Thomson; Christopher D Bayliss; Kornelis Straatman; Paul R Crocker; Ashley Dennison; Luisa Martinez-Pomares; Peter W Andrew; E Richard Moxon; Marco R Oggioni
Journal:  Nat Microbiol       Date:  2018-04-16       Impact factor: 17.745

7.  The role of the spleen in the protective effect of C-reactive protein in Streptococcus pneumoniae infection.

Authors:  S Nakayama; H Gewurz; T Holzer; T W Du Clos; C Mold
Journal:  Clin Exp Immunol       Date:  1983-11       Impact factor: 4.330

Review 8.  Integrative Physiology of Pneumonia.

Authors:  Lee J Quinton; Allan J Walkey; Joseph P Mizgerd
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

9.  Increased resistance of splenectomized mice to Sporothrix schenckii infection.

Authors:  M Miyaji; K Nishimura
Journal:  Mycopathologia       Date:  1986-12       Impact factor: 2.574

10.  Haemophilus influenzae b infection in rats: effect of splenectomy on bloodstream and meningeal invasion after intravenous and intranasal inoculations.

Authors:  E R Moxon; J F Goldthorn; A D Schwartz
Journal:  Infect Immun       Date:  1980-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.